Central venous catheterization can cause various complications. Inadvertent subclavian artery catheterization was performed during insertion of a central venous catheter in a 73-year-old man suffering from panperitonitis due to small-bowel perforation. Endovascular treatment was conducted to treat the injured subclavian artery with a FemoSeal vascular closure device.
INTRODUCTION
Central venous catheterization (CVC) is commonly used for hemodynamic monitoring, rapid large-volume replacement, antibiotic administration, and hemodialysis. However, inadvertent arterial puncture or arterial placement frequently occurs during insertion of a central venous catheter (1) . Iatrogenic arterial injury at a non-compressible site can lead to serious complications, including fatal hemorrhage, while the catheter is removed. This complication can be treated by traditional surgical approaches or endovascular treatment. We report a rare case of inadvertent puncture of the subclavian artery during CVC that was successfully managed with a FemoSeal (St. Jude Medical Systems, Uppsala, Sweden) closure device. This study was approved by the Institutional Review Board. The requirement for obtaining informed consent was waived because of the retrospective nature of the study.
CASE REPORT
A 73-year-old man was admitted with peritonitis secondary to small bowel perforation. Following laparotomic small bowel resection, attempts were made to place a central line in the intensive care unit. A 7 French (Fr) catheter was introduced via the right subclavian approach. Post-procedural chest radiography revealed that the catheter projected to the left of the intended position, suggesting inadvertent arterial placement (Fig. 1A) (Fig. 1F) .
Final angiography obtained immediately after the deployment of the FemoSeal device showed preservation of the major arteries, no signs of contrast medium extravasation or pseudoaneurysm, and confirmed procedural success (Fig. 1G ). During his hospital stay, the patient experienced no neurological deficits. the tract needed to close the arteriotomy site using a VCD depends on the maximum working length of the VCD. The FemoSeal might be considered as long as the length of the tract is less than 10 cm, which is the maximum working length of a FemoSeal. In our case, the length of the tract from the skin entry site was 6 cm. Hence, we successfully used the FemoSeal.
In conclusion, endovascular management of inadvertent subclavian artery injury induced by CVC using a FemoSeal VCD may be safe and effective without the need for surgical management. These results are expected to be helpful in the management of inadvertent subclavian artery cannulation.
